CY1112481T1 - Αντι-μολυσματικο διαλυμα που περιλαμβανει μια ενωση του τυπου πυριδο(3,2,1-ij)-βενζοξαδιαζινης - Google Patents

Αντι-μολυσματικο διαλυμα που περιλαμβανει μια ενωση του τυπου πυριδο(3,2,1-ij)-βενζοξαδιαζινης

Info

Publication number
CY1112481T1
CY1112481T1 CY20111101104T CY111101104T CY1112481T1 CY 1112481 T1 CY1112481 T1 CY 1112481T1 CY 20111101104 T CY20111101104 T CY 20111101104T CY 111101104 T CY111101104 T CY 111101104T CY 1112481 T1 CY1112481 T1 CY 1112481T1
Authority
CY
Cyprus
Prior art keywords
gen
substituted
optionally
benzoxadiasin
pyrid
Prior art date
Application number
CY20111101104T
Other languages
English (en)
Inventor
Marinette Moreau
Original Assignee
Sa Vetoquinol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sa Vetoquinol filed Critical Sa Vetoquinol
Publication of CY1112481T1 publication Critical patent/CY1112481T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Η παρούσα εφεύρεση αφορά ένα αντι-μολυσματικό διάλυμα που περιλαμβάνει τουλάχιστον μια ένωση του τύπου πυριδο(3,2,1-ij)-βενζοξαδιαζίνης που αντιστοιχεί στον ακόλουθο τύπο (Ι):
CY20111101104T 2006-01-24 2011-11-16 Αντι-μολυσματικο διαλυμα που περιλαμβανει μια ενωση του τυπου πυριδο(3,2,1-ij)-βενζοξαδιαζινης CY1112481T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0650246A FR2896416B1 (fr) 2006-01-24 2006-01-24 Composition anti-infectieuse comprenant un compose de type pyrido (3,2,1-ij)-benzoxadiazine
EP07731510A EP1976561B1 (fr) 2006-01-24 2007-01-24 Solution anti-infectieuse comprenant un compose de type pyrido(3,2,1-ij)-benzoxadiazine

Publications (1)

Publication Number Publication Date
CY1112481T1 true CY1112481T1 (el) 2015-12-09

Family

ID=36748355

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111101104T CY1112481T1 (el) 2006-01-24 2011-11-16 Αντι-μολυσματικο διαλυμα που περιλαμβανει μια ενωση του τυπου πυριδο(3,2,1-ij)-βενζοξαδιαζινης

Country Status (25)

Country Link
US (1) US8796265B2 (el)
EP (2) EP1976561B1 (el)
JP (1) JP5221383B2 (el)
CN (1) CN101405032B (el)
AT (1) ATE520418T1 (el)
AU (1) AU2007209245B2 (el)
BR (1) BRPI0706956B1 (el)
CA (1) CA2637941C (el)
CY (1) CY1112481T1 (el)
DK (1) DK1976561T3 (el)
EA (1) EA016154B1 (el)
ES (2) ES2813856T3 (el)
FR (1) FR2896416B1 (el)
HK (1) HK1128883A1 (el)
HU (1) HUE050643T2 (el)
IL (1) IL192935A (el)
MX (1) MX2008009470A (el)
NO (1) NO20083422L (el)
NZ (1) NZ570332A (el)
PL (2) PL2438929T3 (el)
PT (2) PT1976561E (el)
SI (2) SI2438929T1 (el)
UA (1) UA94086C2 (el)
WO (1) WO2007085760A2 (el)
ZA (1) ZA200806369B (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2928150A1 (fr) 2008-02-29 2009-09-04 Vetoquinol Sa Sa Nouveaux derives 7-substitues de 3-carboxy-oxadiazino-quinolones, leur preparation et leur application comme anti-bacteriens
EP2145891A1 (en) 2008-07-09 2010-01-20 Vetoquinol S.A. 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
EP2332916A3 (en) 2009-11-19 2011-08-03 Krka Tovarna Zdravil, D.D., Novo Mesto A process for a preparation of marbofloxacin and intermediate thereof
CN103271875A (zh) * 2013-07-01 2013-09-04 浙江华尔成生物药业股份有限公司 一种注射用麻保沙星冻干粉及其制备方法与应用
US10519409B2 (en) * 2014-12-31 2019-12-31 Ge Healthcare Bio-Sciences Corp. Shaft-mounted fluid transfer assembly for a disposable bioreactor
US10440147B2 (en) 2015-11-24 2019-10-08 William Edward Woodcock, IV Quality-of-service management for domain name service
US20170239250A1 (en) 2016-02-19 2017-08-24 Eagle Pharmaceuticals, Inc. Pemetrexed formulations
CN107445977B (zh) * 2017-07-13 2019-08-09 江西傲新生物科技有限公司 一种水溶性马波沙星及其制备方法与应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
DE3788177D1 (de) * 1986-09-12 1993-12-23 Hoffmann La Roche Pyrido [3,2,1-ij]-1,3,4-benzoxadiazinderivate, Verfahren zu deren Herstellung, entsprechende pharmazeutische Präparate und im Verfahren verwendbare Zwischenprodukte.
DE19500784A1 (de) * 1995-01-13 1996-07-18 Bayer Ag Enrofloxacin-Injektions- oder Infusionslösungen
DE19519822A1 (de) * 1995-05-31 1996-12-05 Bayer Ag Neue antibakterielle Mittel
PL186795B1 (pl) 1995-12-21 2004-02-27 Pfizer Preparat farmaceutyczny zawierający danofloksacynę
GB9600894D0 (en) * 1996-01-17 1996-03-20 Pfizer Novel compound
GB9600886D0 (en) * 1996-01-17 1996-03-20 Pfizer Novel compound
GB9601356D0 (en) * 1996-01-24 1996-03-27 Pfizer Novel compound
DE19633480A1 (de) * 1996-08-20 1998-02-26 Bayer Ag Oral applizierbare Formulierungen von Chinolon- und Naphthyridoncarbonsäuren
DE10337191A1 (de) * 2003-08-13 2005-03-17 Bayer Healthcare Ag Neue Verwendung von Chinolon-Antibiotika
CA2546195A1 (en) * 2003-11-21 2005-06-02 Pfizer Products Inc. The use of anti biotics as vaccine adjuvants

Also Published As

Publication number Publication date
PT2438929T (pt) 2020-09-01
WO2007085760A2 (fr) 2007-08-02
EP2438929A3 (fr) 2012-07-18
BRPI0706956B1 (pt) 2019-08-13
EP2438929A2 (fr) 2012-04-11
WO2007085760A3 (fr) 2007-10-11
SI2438929T1 (sl) 2020-10-30
DK1976561T3 (da) 2011-12-05
NO20083422L (no) 2008-10-08
IL192935A0 (en) 2009-02-11
ES2813856T3 (es) 2021-03-25
BRPI0706956A2 (pt) 2011-04-12
CN101405032A (zh) 2009-04-08
EA016154B1 (ru) 2012-02-28
EP2438929B1 (fr) 2020-06-10
ATE520418T1 (de) 2011-09-15
US8796265B2 (en) 2014-08-05
EP1976561B1 (fr) 2011-08-17
UA94086C2 (ru) 2011-04-11
HUE050643T2 (hu) 2020-12-28
FR2896416B1 (fr) 2010-08-13
FR2896416A1 (fr) 2007-07-27
PL1976561T3 (pl) 2012-01-31
CA2637941A1 (fr) 2007-08-02
PT1976561E (pt) 2011-11-17
AU2007209245A1 (en) 2007-08-02
PL2438929T3 (pl) 2020-12-14
ZA200806369B (en) 2009-08-26
NZ570332A (en) 2010-09-30
JP2009523840A (ja) 2009-06-25
HK1128883A1 (en) 2009-11-13
EA200801733A1 (ru) 2008-12-30
AU2007209245B2 (en) 2013-09-12
JP5221383B2 (ja) 2013-06-26
US20100280022A1 (en) 2010-11-04
CN101405032B (zh) 2013-01-16
EP1976561A2 (fr) 2008-10-08
SI1976561T1 (sl) 2011-12-30
MX2008009470A (es) 2008-09-23
CA2637941C (fr) 2014-01-21
ES2371941T3 (es) 2012-01-11
IL192935A (en) 2014-02-27

Similar Documents

Publication Publication Date Title
CY1112481T1 (el) Αντι-μολυσματικο διαλυμα που περιλαμβανει μια ενωση του τυπου πυριδο(3,2,1-ij)-βενζοξαδιαζινης
MX2007010072A (es) Derivados de piperidina antibacterianos.
MY148688A (en) 2-methylmorpholine pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors
MX2010009163A (es) Derivados heterociclicos de urea y metodos de uso de los mismos-211.
TNSN08407A1 (en) Organic compounds
TW200637869A (en) The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
MY140638A (en) New heterocyclic compounds, which are active as inhibitors of beta-lactamases
TW200502230A (en) Dual nk1/nk3 derivatives
MY162940A (en) Quinoline derivative-containing pharmaceutical composition
TW200637839A (en) 1-thio-d-glucitol derivatives
DE602006021539D1 (en) Morpholine als 5ht2c-agonisten
MX2009012125A (es) Compuestos terapeuticos.
MX2010013310A (es) Derivados de heterociclil urea para el tratamiento de infecciones bacterianas.
UA96304C2 (en) 2-METHYLMORPHOLINE PYRIDO-, PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
ZA202308282B (en) Toxin molecule suitable for antibody-drug conjugate
MXPA04000407A (es) Derivados de fenilacetamido-tiazol, procedimiento para su preparacion y uso como agentes antitumorales.
IL195837A0 (en) 4-amino-3-arylamino-6-arylpyrazolo[3,4-d]
WO2009016081A3 (en) Benzoind0l-2-one derivatives for use in therapy
MX2009012124A (es) Compuestos terapeuticos estereoisomeros de propofol.
MX2009005250A (es) Compuestos 2-alquil-indazol para el tratamiento de ciertas enfermedades relacionadas con el sistema nervioso central (cns).
PL1989208T3 (pl) Nowe związki morfiny do kompozycji farmaceutycznych
MXPA05013717A (es) Derivados de acido 2-etoxi-2-fenilpropionico para el tratamiento de trastornos de lipido.
UA94735C2 (ru) Производные пурина, предназначенные для применения в качестве агонистов аденозинового рецептора а2а
MX2007007391A (es) Compuestos que interactuan con canales de iones, en particular con canales de iones de la familia kv.
UA91531C2 (en) 1-thio-d-glucitol derivatives